Heartburn drug renamed to avoid medicinal mix-ups.
The AP (3/4) reported that the FDA "said Thursday that Takeda Pharmaceuticals will change the name of a heartburn drug that has repeatedly been confused by pharmacists with drugs meant to treat cancer and other ailments." The drug, Kapidex (dexlansoprazole), has been mistaken for "Casodex [bicalutamide], a prostate cancer drug, and Kadian [morphine extended-release], a narcotic pain reliever."
Although "there is no problem with Kapidex itself," HealthDay (3/4, Roberts) reports, the newly-named Dexilant will "begin appearing on store shelves in late April." Medscape (3/4, Hitt) also covered the change.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment